KANE BIOTECH INC (KNE.CA) Stock Balance Sheet
TSX-V:KNE - TSX Venture Exchange - CA4838092084 - Common Stock - Currency: CAD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 493.60K | 358.80K | 749.30K | 1.10M | 1.15M | |||
| Receivables | 204.00K | 88.10K | 103.10K | 1.06M | 1.07M | |||
| Inventories | 157.60K | 376.00K | 250.40K | 763.50K | 519.20K | |||
| Other Current Assets | 440.00K | 205.90K | 2.62M | 342.00K | 137.20K | |||
| Total Current Assets | 1.30M | 1.03M | 3.72M | 3.10M | 2.88M | |||
| Non-Current Assets | ||||||||
| PPE Net | 902.20K | 929.30K | 1.07M | 1.25M | 1.44M | |||
| Intangibles | 558.50K | 536.10K | 733.30K | 826.50K | 828.60K | |||
| Other Non-Current Assets | N/A | 0.00 | 158.80K | 444.20K | 859.30K | |||
| Total Non-Current Assets | 1.46M | 1.47M | 1.96M | 2.52M | 3.25M | |||
| TOTAL ASSETS | 2.76M | 2.49M | 5.68M | 5.62M | 6.13M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 6.63M | 4.00M | 2.38M | |||
| Current Portion Of LT Debt. | 475.60K | 461.70K | 450.40K | 278.20K | 132.60K | |||
| Accounts Payable | 959.30K | 1.19M | 437.00K | 602.80K | 626.20K | |||
| Other Current Liabilities | 865.80K | 762.10K | 3.38M | 1.46M | 1.58M | |||
| Total Current Liabilities | 2.30M | 2.41M | 10.89M | 6.34M | 4.72M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 1.59M | 1.71M | 2.18M | 2.58M | 2.20M | |||
| Other Non-Current Liabilities | N/A | 0.00 | 1.02M | 837.30K | 777.00K | |||
| Total Non-Current Liabilities | 1.59M | 1.71M | 5.34M | 5.80M | 5.30M | |||
| TOTAL LIABILITIES | 3.89M | 4.12M | 16.24M | 12.14M | 10.02M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -35.62M | -34.35M | -41.99M | -37.10M | -31.55M | |||
| Additional Paid In Capital | 8.53M | 8.32M | 7.75M | 7.44M | 5.51M | |||
| Minority Interest | N/A | 0.00 | 2.15M | 2.38M | 2.32M | |||
| Common Shares | 25.96M | 24.40M | 23.69M | 23.13M | 22.16M | |||
| Other Shareholders' Equity | N/A | N/A | N/A | N/A | N/A | |||
| Shares Outstanding | 154.77M | 137.79M | 131.84M | 124.83M | 114.81M | |||
| Tangible Book Value per Share | -0.01 | -0.02 | -0.09 | -0.06 | -0.04 | |||
| Total Shareholders' Equity | -1.13M | -1.63M | -10.56M | -6.52M | -3.89M | |||
| TOTAL LIABILITIES AND EQUITY | 2.76M | 2.49M | 5.68M | 5.62M | 6.13M | |||
| Statistics | ||||||||
| Debt/Equity | -1.40 | -1.05 | -0.83 | -1.01 | -1.18 | |||
| Current Ratio | 0.56 | 0.43 | 0.34 | 0.49 | 0.61 | |||
| Return On Assets (ROA) | 225.92% | 244.48% | -88.61% | -69.22% | -75.06% | |||
| Return On Equity (ROE) | N/A | N/A | N/A | N/A | N/A | |||
All data in CAD , ROIC based on taxRate of 0.28